Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention1: VTM (Viral transport media): Viral transport media
Control Intervention1: MTM (Molecular Transport Media): Molecular Transport Media
Sponsors
Tata Memorial Centre
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age >= 18 years. 2. Asymptomatic patient planned for cancer surgery or any other procedure requiring general anaesthesia (DL Scopy/ cystoscopy/ PTBD/ PCN insertion). 3. Asymptomatic patient planned for in patient multiday chemotherapy in ward. 4. Symptomatic patient planned for COVID-19 swabbing by their treating physician. 5. Symptomatic staff planned for COVID-19 swabbing by the staff physician.
Exclusion criteria
Exclusion criteria: 1. Participant not willing to participate in the study. 2. Participant on anticoagulation therapy or antiplatelet therapy for other ailments.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The difference between RT PCR COVID-19 positivity in samples transported in MTM and VTM media.Timepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To assess the SARS Cov 2 positivity rate among symptomatic staff undergoing swabbing 2. To compare the N gene/ E gene/ RaRP/ Orf1 positivity difference in MTM versus VTM media. 3. Analyse potential impact of false negative patients difference.Timepoint: 3 months | — |
Countries
India
Contacts
Public ContactDr Amit Joshi
Tata Memorial Hospital
Outcome results
None listed